Global Hepatitis C Epidemiology and Patient Flow

Global Hepatitis C Epidemiology and Patient Flow Analysis – 2021, provides Hepatitis C epidemiology, demographics, and patient flow. The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.

The research provides population data to characterize Hepatitis C patients, history of the disease at the population level (Hepatitis C prevalence, Hepatitis C incidence) and at the clinical level (from diagnosis to treated patients). It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.

Research scope:

• Hepatitis C patient flow: Hepatitis C prevalence, diagnosed, and drug-treated patients
• Countries: US, Germany, France, Italy, Spain, UK, Japan, G7 Countries
• Demographics: Hepatitis C patients by age group, gender
• Forecast: Hepatitis C epidemiology forecast to 2030

The data from this research will help executives –

• Establish basis for Hepatitis C market sizing, assessing market potential, and developing drug forecast models
• Identify Hepatitis C patients segments through age groups, gender, and disease sub-types
• Develop Hepatitis C population-based health management frameworks
• Evaluate Hepatitis C market opportunities, identify target patient population
• Align marketing decisions with the Hepatitis C target population
• Communicate leadership and health authorities about your Hepatitis C target patient population